Workflow
Newsfile
icon
Search documents
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Perrigo Company plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRGO
Newsfile· 2025-11-22 01:41
Core Viewpoint - A class action lawsuit has been filed against Perrigo Company plc for allegedly misleading investors regarding its financial health and operations, particularly concerning its infant formula business acquired from Nestlé [2][6]. Group 1: Lawsuit Details - The class action lawsuit pertains to securities purchased between February 27, 2023, and November 4, 2025, and investors must act by January 16, 2026, to serve as lead plaintiffs [2][4]. - Allegations include that Perrigo made materially false statements and failed to disclose significant underinvestment and manufacturing deficiencies in its infant formula business, leading to overstated financial results [6]. Group 2: Investor Guidance - Investors who purchased Perrigo securities during the class period may be entitled to compensation without upfront costs through a contingency fee arrangement [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [5].
Metalero Mining (MLO) Announces Extension of Private Placement
Newsfile· 2025-11-22 01:20
Core Viewpoint - Metalero Mining Corp. is extending its price protection for a non-brokered private placement to December 9, 2025, to complete subscriptions for its Offering [1] Group 1: Offering Details - The Offering consists of up to 1,428,572 flow-through units priced at $0.21 per unit, each unit includes one flow-through common share and one common share purchase warrant [2] - Each warrant allows the holder to purchase an additional non flow-through common share at a price of $0.26 for two years from issuance [2] - The first tranche of the Offering closed on October 21, 2025, with the sale of 952,381 flow-through units [2] Group 2: Use of Proceeds - Proceeds from the Offering will be utilized to support the Fall 2025 exploration work at the Benson Project, including further sampling and ground geophysics [3] Group 3: Tax Implications - All flow-through shares offered qualify as "flow-through shares" under the Income Tax Act (Canada), and qualifying individuals under the BC Tax Act will have these expenditures qualify as "BC flow-through mining expenditures" [4] Group 4: Conditions and Approvals - The Offering is subject to conditions including necessary approvals from the TSX Venture Exchange, and all securities issued will have a hold period of four months and a day after the closing date [5] Group 5: Company Overview - Metalero Mining Corp. is a Canadian junior exploration company focused on copper and gold projects in North America, with its flagship Benson Project covering 166 square kilometers and hosting five prospects containing gold and copper [7]
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages James Hardie Industries plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - JHX
Newsfile· 2025-11-22 00:55
Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of James Hardie Industries plc between May 20, 2025, and August 18, 2025, about the December 23, 2025, deadline to become a lead plaintiff in a class action lawsuit [2][4]. Group 1: Class Action Details - Investors who bought James Hardie common stock during the specified period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed against James Hardie Industries plc, alleging that the company misled investors regarding the strength of its North America Fiber Cement segment during the class period [6]. - The lawsuit claims that James Hardie falsely asserted that demand remained strong and stock levels were "normal," despite knowing that distributors were destocking inventory [6]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms issuing notices may lack the necessary experience and resources [5]. - The Rosen Law Firm has a history of successful settlements in securities class actions, including the largest settlement against a Chinese company and significant recoveries for investors in recent years [5].
ROSEN, A LEADING LAW FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
Newsfile· 2025-11-22 00:51
Core Viewpoint - Rosen Law Firm is encouraging investors of Inspire Medical Systems, Inc. to secure legal counsel before the January 5, 2026 deadline for a class action lawsuit related to the company's stock performance during the specified class period [1][3]. Group 1: Class Action Details - The class period for the Inspire Medical Systems, Inc. stock is from August 6, 2024, to August 4, 2025, inclusive [1]. - Investors who purchased common stock during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and potential lead plaintiffs must act by January 5, 2026 [3]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [4]. Group 3: Case Allegations - The lawsuit alleges that Inspire Medical Systems misrepresented key facts about its Inspire V sleep apnea device, including market demand and readiness for launch, leading to misleading statements that inflated investor confidence [5].
Arya Resources Ltd. Engages Independent Trading Group as Market Maker
Newsfile· 2025-11-22 00:45
Vancouver, British Columbia--(Newsfile Corp. - November 21, 2025) - Arya Resources Ltd. (TSXV: RBZ) ("Arya" or the "Company") is pleased to announce that, subject to regulatory approval, it has engaged Independent Trading Group ("ITG") to provide market-making services in accordance with the policies of the TSX Venture Exchange.ITG will trade the Company's common shares on the TSXV and all other applicable trading venues with the objective of maintaining a reasonable market and improving liquidity.Under th ...
Valkea Cancels Non-Brokered Private Placement
Newsfile· 2025-11-22 00:30
Core Viewpoint - Valkea Resources Corp. has announced the cancellation of its previously planned non-brokered private placement under the Listed Issuer Financing exemption [1] Company Overview - Valkea Resources is focused on gold exploration in Finland's Central Lapland Greenstone Belt, with a strong portfolio of high-potential projects, including the flagship Paana project [2]
Nexcel Gives an Update to Private Placement
Newsfile· 2025-11-22 00:00
Core Viewpoint - Nexcel Metals Corp. is conducting a non-brokered private placement to raise up to $3,500,000 through the issuance of flow-through (FT) and non-flow-through (NFT) units, aimed at funding exploration activities and general expenses [1][2]. Group 1: Private Placement Details - The private placement will consist of up to 1,190,476 FT Units priced at $0.42 each for gross proceeds of up to $500,000, and up to 8,571,428 NFT Units priced at $0.35 each for gross proceeds of up to $3,000,000 [9]. - Each FT Unit includes one flow-through common share and one warrant, allowing the purchase of a non-flow-through common share at $0.50 for 24 months [3]. - Each NFT Unit consists of one non-flow-through common share and one warrant, allowing the purchase of a non-flow-through common share at $0.45 for 24 months [4]. Group 2: Use of Proceeds - Gross proceeds from the FT Units will be allocated to Canadian exploration expenses on the Lac Ducharme Property in Quebec and the Burnt Hill Property in New Brunswick, qualifying as flow-through mining expenditures [5]. - Net proceeds from the NFT Units will be used for additional exploration work, general administrative expenses, and working capital [7]. Group 3: Regulatory and Approval Aspects - The private placement is not subject to a minimum aggregate offering amount, and there are no undisclosed material facts related to the company [2]. - The issuance of securities may exceed 100% of the current number of outstanding common shares, requiring shareholder approval, which has been obtained from shareholders holding over 50% of the outstanding shares as of November 7, 2025 [6]. Group 4: Closing and Hold Period - The closing of the private placement is anticipated around December 5, 2025, subject to customary conditions, with all securities issued being subject to a four-month and one-day statutory hold period from the closing date [8].
Luxxfolio Announces $1 Million Non-Brokered Private Placement
Newsfile· 2025-11-21 23:47
Group 1 - LUXXFOLIO Holdings Inc. announced a non-brokered private placement of up to 5,882,352 units at a price of $0.17 per unit, aiming for gross proceeds of up to $1,000,000 [1] - Each unit consists of one common share and one share purchase warrant, with the warrant allowing the purchase of an additional share at an exercise price of $0.35 for 24 months [1] - The company may pay finder's fees in accordance with applicable securities laws and the completion of the offering is subject to customary conditions and necessary approvals [2] Group 2 - The net proceeds from the offering will be used for general working capital and the development of Litecoin mining initiatives [2] - LUXXFOLIO is focused on enabling crypto-powered commerce and is developing on-chain technologies for real-world cryptocurrency use cases, including stablecoin payments and merchant processing [4] - The company has adopted a Litecoin treasury strategy as part of its long-term vision to accelerate mainstream adoption of cryptocurrency for everyday payments [4]
DeepMarkit Closes Second and Final Private Placement Tranche
Newsfile· 2025-11-21 23:46
Core Insights - DeepMarkit Corp. has successfully closed the second and final tranche of its non-brokered private placement, raising gross proceeds of $624,999.96, bringing the total to $2.16 million from the issuance of 35,999,998 common shares [1][2][3] Group 1: Private Placement Details - The second tranche of the private placement was completed in connection with DeepMarkit's acquisition of Prospect Prediction Markets Inc. [2] - The total gross proceeds from both tranches will be utilized for various purposes, including repayment of existing company debt, payment obligations to Prospect Labs Inc., platform development and expansion, marketing, and general corporate purposes [7] Group 2: Strategic Focus - Following the completion of the private placement, the company aims to accelerate user acquisition and establish strategic partnerships to enhance its competitive position in the digital entertainment sector [3] - The acquisition of Prospect Prediction Markets is expected to enable DeepMarkit to offer innovative, blockchain-powered prediction markets to a wider audience [3] Group 3: About Prospect Prediction Markets - Prospect Prediction Markets is a platform designed for sports fan engagement, allowing users to participate in free-to-play sports predictions using a ranking algorithm on the Avalanche blockchain [4] - The platform aims to transform passive sports viewership into active participation, enhancing fans' connection to their favorite sports [4] Group 4: About DeepMarkit - DeepMarkit Corp. is focused on building and acquiring platforms that facilitate next-generation digital experiences across various technologies, including prediction markets and blockchain [5] - The company targets emerging ecosystems where innovative technologies can drive user engagement and long-term value [5]
Defence Therapeutics Announces Convertible Debenture Conversion
Newsfile· 2025-11-21 23:02
Core Insights - Defence Therapeutics Inc. has announced the conversion of its 8% convertible debentures into common shares, totaling 2,607,600 shares upon maturity on November 16, 2025 [1][2] Group 1: Financial Details - The principal amount of $1,476,000 was converted into 2,460,000 shares at a conversion price of $0.60 per share [2] - An aggregate amount of $118,080 of accrued interests was converted into 147,600 shares at $0.80 per share, bringing the total conversion value to $1,594,080 [2] Group 2: Company Overview - Defence Therapeutics is a publicly-traded biotechnology company focused on developing next-generation antibody-drug conjugates (ADCs) using its proprietary ACCUM® technology [3] - The ACCUM® technology allows for precision delivery of ADCs to target cells, enhancing efficacy and potency against cancer [3]